Skip to main content

Table 2 Results of follow-up and clinical visits 1 = median follow-up time in years, starting from the introduction of the new follow-up scheme; 2 = number of outpatient clinical visits to the surgeon for follow-up of CRC

From: Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

  CEAwatch Usual Care P
Median study follow-up time1 (range) 0.96 ( 0.10-1.39 ) 1.34 (0.10-1.66) 0.01
Median total follow-up time (range) 2.66 (0.2-10.8 ) 3.21 (0.10-6.05) 0.35
Outpatient clinics2 0 ( 0-7 ) 3 ( 0-10 ) <0.001
Metastases found in follow-up (%) 16 (9) 8 (13) 0.06
Curative metastasectomy 7/16 1/8 0.13